Legal & General Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Buy
25,172
+21,529
+591% +$432K ﹤0.01% 2379
2025
Q4
$85.3K Sell
3,643
-301
-8% -$6.53K ﹤0.01% 2651
2025
Q3
$78.7K Sell
3,944
-69
-2% -$1.24K ﹤0.01% 2659
2025
Q2
$55K Buy
4,013
+138
+4% +$1.32K ﹤0.01% 2696
2025
Q1
$42.9K Sell
3,875
-15,970
-80% -$170K ﹤0.01% 2747
2024
Q4
$211K Buy
19,845
+3,920
+25% +$46.9K ﹤0.01% 2656
2024
Q3
$202K Buy
15,925
+12,311
+341% +$183K ﹤0.01% 2679
2024
Q2
$60.6K Buy
3,614
+829
+30% +$11.8K ﹤0.01% 2768
2024
Q1
$41.8K Sell
2,785
-83
-3% -$1.36K ﹤0.01% 2802
2023
Q4
$43K Buy
2,868
+738
+35% +$9.58K ﹤0.01% 2827
2023
Q3
$29.8K Sell
2,130
-175
-8% -$2.81K ﹤0.01% 2923
2023
Q2
$23.9K Buy
+2,305
New +$25.4K ﹤0.01% 3033
2022
Q2
Sell
-9,857
Closed -$86K 3659
2022
Q1
$86K Buy
9,857
+7,068
+253% +$55.1K ﹤0.01% 2903
2021
Q4
$27K Hold
2,789
﹤0.01% 3187
2021
Q3
$47K Hold
2,789
﹤0.01% 2995
2021
Q2
$42K Hold
2,789
﹤0.01% 3006
2021
Q1
$54K Sell
2,789
-435
-13% -$9.23K ﹤0.01% 2794
2020
Q4
$58K Hold
3,224
﹤0.01% 2763
2020
Q3
$62K Sell
3,224
-803
-20% -$18.2K ﹤0.01% 2621
2020
Q2
$105K Sell
4,027
-53
-1% -$1.29K ﹤0.01% 2513
2020
Q1
$73K Sell
4,080
-893
-18% -$24.1K ﹤0.01% 2496
2019
Q4
$166K Buy
4,973
+746
+18% +$20.4K ﹤0.01% 2441
2019
Q3
$100K Hold
4,227
﹤0.01% 2518
2019
Q2
$140K Buy
4,227
+3,319
+366% +$122K ﹤0.01% 2436
2019
Q1
$33K Buy
908
+536
+144% +$22.5K ﹤0.01% 2892
2018
Q4
$16K Hold
372
﹤0.01% 3174
2018
Q3
$17K Hold
372
﹤0.01% 3250
2018
Q2
$18K Buy
+372
New +$21.6K ﹤0.01% 3215

Other funds holding URGN